Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Sugar showdown: could galactose be the key to steadier blood sugar?

NCT ID NCT07599683

Knowledge-focused Sponsor: University of Bath Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jul 09, 2026 · Updated 3 times

Summary

This study is testing whether adding a small amount of galactose (a type of sugar) to a meal can help control blood sugar spikes. Twenty-five healthy adults will drink a sugary solution with and without galactose, and researchers will track how their bodies process the sugar. The goal is to understand how galactose might slow sugar absorption or increase sugar uptake by muscles.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
galactose
What this could lead to
If it works, this could point toward a simple dietary strategy to help manage blood sugar levels after meals.
What could go wrong
This is a small, early-stage study in healthy people only, so results may not apply to those with diabetes or other conditions. The effect may be small or not meaningful.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 25 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2026

Expected to finish

Dec 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age: 18 years and above; * Normoglycaemic (fasting glucose \<6.1 mmol/L) * Body mass index: 18.5-30 kg/m2 Exclusion Criteria: * weight instability (\>5% change within last 3 months); * pregnant or lactating; * following a very low-carbohydrate (ketogenic) diet; * diagnosis of diabetes or prediabetes, or any other metabolic disease; * dietary intolerances or allergies, or to any other study procedures; * disorders in the ability to metabolise galactose or fructose (e.g., galactosemias); * diagnosis of any gastrointestinal disorders; * any other condition/medications that could introduce bias; * unable to understand and follow study procedures

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Glucose are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Glucose

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University of Bath

    RECRUITING

    Bath, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.